Biosyent (TSXV:RX) Buildings And Improvements : C$1.33 Mil (As of Mar. 2025)

View and export this data going back to 1979. Start your Free Trial

What is Biosyent Buildings And Improvements?

Biosyent's quarterly buildings and improvements stayed the same from Sep. 2024 (C$1.33 Mil) to Dec. 2024 (C$1.33 Mil) and stayed the same from Dec. 2024 (C$1.33 Mil) to Mar. 2025 (C$1.33 Mil).

Biosyent's annual buildings and improvements stayed the same from Dec. 2022 (C$1.33 Mil) to Dec. 2023 (C$1.33 Mil) and stayed the same from Dec. 2023 (C$1.33 Mil) to Dec. 2024 (C$1.33 Mil).

Biosyent Buildings And Improvements Historical Data

The historical data trend for Biosyent's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyent Buildings And Improvements Chart

Biosyent Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buildings And Improvements

Get a 7-Day Free Trial

1.33

Biosyent Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Buildings And Improvements	Get a 7-Day Free Trial															1.33	1.33	1.33	1.33	1.33

Biosyent Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Biosyent Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biosyent Inc (TSXV:RX) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

BIOYF:USA

Address

2476 Argentia Road, Suite 402, Toronto, Mississauga, ON, CAN, L5N 6M1

Website

http://www.biosyent.com

Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.

Executives

Peter Douglas Lockhard	Director
Blair Driscoll	10% Security Holder
Merrilyn Joy Driscoll	10% Security Holder
Sean Driscoll	10% Security Holder
Fax Capital Corp.	10% Security Holder
Fax Investments Inc.	10% Security Holder
Federated Capital Corp.	10% Security Holder
Seyed Ahmad Ashrafi	Director
Robert Joseph March	Senior Officer
Sharan Raghubir	Senior Officer
Rene Goehrum	10% Security Holder, Director, Senior Officer
Biosyent Inc.	Issuer
Joost Van Der Mark	Senior Officer
Sara Elford	Director
Alfred D'souza	Director

Biosyent Headlines

No Headlines